ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT

ARS Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-44.88M -33.94M 49.93M -19.13M -12.52M -10.29M -7.17M -14.87M -17.37M -14.96M -14.43M -6.58M -6.42M -7.25M -23.46M -22.66M -24.5M -18.87M
Depreciation & Amortization
279K -1.68M -1.51M 21K 18K 11K 12K 21K 20K 20K 299K 7K -37K 50K 430K 541K 492K 466K
Stock-Based Compensation
5.37M 5.3M 4.26M 3.59M 3.37M 3.31M 2.28M 2.61M 2.1M 2.25M 4.76M 460K 356K 264K 162K 912K 877.5K 877.5K
Other Working Capital
n/a -5.01M -9.54M -5.99M 692K 892K -1.89M -91K 111K -2.69M -12.53M 6.84M 2.42M 12K -3.04M -1.66M 557K -294K
Other Non-Cash Items
-359K n/a n/a 7.04M -1.9M -1.98M 9.43M -1.56M -1.75M -1.81M 931K 40K 83K -1K 6.4M 6.47M 1.13M 3.01M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -11.18M n/a n/a n/a 143K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -10.42M -10.68M -5.99M 3.76M 2.24M -10.77M 1.03M 335K 2.07M -12.2M 394K -956K 12K -3.43M -2.02M 5.14M 1.91M
Operating Cash Flow
-39.59M -40.74M 42M -14.47M -7.28M -6.71M -17.41M -12.76M -16.67M -12.43M -20.5M -5.68M -6.97M -6.92M -21.3M -19.12M -14.13M -12.2M
Capital Expenditures
-51K -91K -302K -140K -38K -83K 91K -43K -30K -193K -126K -30K -22K -21K -550K -87K -700K -35K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -25.95M 46.6M n/a 111.35M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-31.38M -34.34M -163.46M -41.54M -87.61M -63.43M -34.05M -106.6M n/a -131.35M n/a n/a n/a n/a -25.14M -39.97M n/a n/a
Sales Maturities Of Investments
80M 63.5M 67M 61M 75M 55M 60M 60M 45M 20M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -5M -2.5M n/a n/a 25.95M -46.6M 45M -111.35M n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
48.57M 29.06M -101.76M 16.82M -12.65M -8.51M 26.04M -46.64M 44.97M -111.55M -126K -30K -22K -21K -25.68M -40.06M -700K -35K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5.95M -909K -910K -908K n/a n/a -496K -350K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.7M n/a 69.38M n/a n/a n/a n/a n/a 2.85M 1.32M 199.77M -647K 287K n/a n/a 148K n/a 222K
Financial Cash Flow
2.7M 725K 70.92M 680K 545K 258K 1.8M 921K 2.85M 1.32M 193.82M -1.56M -623K -908K 275K 148K 319K -128K
Net Cash Flow
11.68M -10.95M 11.16M 3.03M -19.38M -14.96M 10.44M -58.48M 31.16M -122.66M 173.2M -7.27M -7.62M -7.85M -46.62M -59.03M -14.52M -12.36M
Free Cash Flow
-39.64M -40.83M 41.7M -14.61M -7.32M -6.79M -17.31M -12.81M -16.7M -12.62M -20.62M -5.71M -7M -6.95M -21.86M -19.21M -14.84M -12.24M